Connection
Kevin Bielamowicz to Maximum Tolerated Dose
This is a "connection" page, showing publications Kevin Bielamowicz has written about Maximum Tolerated Dose.
|
|
Connection Strength |
|
|
|
|
|
0.053 |
|
|
|
-
Saulnier-Sholler G, Duda DG, Bergendahl G, Ebb D, Snuderl M, Laetsch TW, Michlitsch J, Hanson D, Isakoff MS, Bielamowicz K, Kraveka JM, Ferguson W, Carmeliet P, De Deene A, Gijsen L, Jain RK. A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma. Clin Cancer Res. 2022 09 15; 28(18):3950-3957.
Score: 0.053